• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-
-

2010 Warning Letters

Recently Posted | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

Warning Letters issued in 2010

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

Posted on September 14, 2010

Letter Issue Date Company Name Issuing Office Subject Close Out Date
September 01, 2010 Cortechs Labs Inc Los Angeles District Office CGMP/QSR/Manufacture/Packing/Storage/Installation/Adulterated July 18, 2011
August 31, 2010 iVu Imaging Corporation Dallas District Office CGMP/QSR/Adulterated/Manufacture/Packing/Storage/Installation September 19, 2011
August 30, 2010 Dr Pepper Snapple Group Center for Food Safety and Applied Nutrition False & Misleading Claims/Misbranded Not Issued *
August 30, 2010 Reddick Dairy Philadelphia District Office Animal for Slaughter as Food/Adulterated Not Issued *
August 30, 2010 Unlimited Nutrition Atlanta District Office Dietary Supplement/Labeling/Misbranded Not Issued *
August 30, 2010 Bristol Myers Squibb Holdings Pharma., Ltd. San Juan District Office CGMP/QSR/Manufacture/Packing/Storage/Installation/Adulterated June 07, 2011
August 27, 2010 Matthew N. Songer, MD Center for Devices and Radiological Health Investigational Device Exemptions Not Issued *
August 25, 2010 Sun Pharmaceutical Industries Inc New Jersey District Office CGMP for Finished Pharmaceuticals/Adulterated September 13, 2011
August 25, 2010 Flagship Niagara League Inc. Philadelphia District Office PHS Act/Violation July 12, 2011
August 25, 2010 Activa Brand Products, Inc. Center for Devices and Radiological Health CGMP/QSR/Manufacture/Packing/Storage/Installation/Adulterated Not Issued *


 

Contact FDA

301-796-8490
FDA's Office of Critical Path Programs
-
-
-